Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

UroStream

Home » UroStream » Page 4
Professor Ming Liu’s Team Establishes MRI-Based Criteria for Assessing the Difficulty of Intrafascial Excision and Nerve Preservation

Professor Ming Liu’s Team Establishes MRI-Based Criteria for Assessing the Difficulty of Intrafascial Excision and Nerve Preservation

Posted by By Peng Longmei 2026.01.08
Highlights from the 15th Shanghai Urologic Oncology Academic Conference Editor’s Note: The 15th Shanghai Urologic Oncology Academic Conference was grandly held in Pudong, Shanghai, bringing together leading experts in urology…
Read More
Professor Zhisong He: Advances and Unresolved Challenges in the Treatment of Non–Muscle-Invasive Bladder Cancer

Professor Zhisong He: Advances and Unresolved Challenges in the Treatment of Non–Muscle-Invasive Bladder Cancer

Posted by By Mourabit Halima 2025.12.25
Editor’s Note: In the field of bladder cancer management, treatment strategies for non–muscle-invasive bladder cancer (NMIBC) are undergoing major transformation. With the development of novel immunotherapies and precision medicine technologies,…
Read More
Professor Liqun Zhou: Standardized Development and Future Perspectives of Minimally Invasive Surgery for Urologic Tumors

Professor Liqun Zhou: Standardized Development and Future Perspectives of Minimally Invasive Surgery for Urologic Tumors

Posted by By Peng Longmei 2025.12.25
Editor’s Note: With the rapid advancement of modern medical technology, urologic surgery has undergone a series of transformative changes. From traditional open surgery to minimally invasive approaches, and now to…
Read More
Precision Integration, Intelligent Leadership — Prof. Ye Dingwei Highlights the 15th Shanghai Urologic Oncology Conference

Precision Integration, Intelligent Leadership — Prof. Ye Dingwei Highlights the 15th Shanghai Urologic Oncology Conference

Posted by By Mourabit Halima 2025.12.25
Editor’s Note: With sails raised and talents converging, the 15th Shanghai Urologic Oncology Academic Conference, hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of…
Read More
Professor Bo Dai Interprets the 2025 Expert Consensus on Full-Course Prostate Cancer Management | 15th Shanghai Urological Oncology Conference

Professor Bo Dai Interprets the 2025 Expert Consensus on Full-Course Prostate Cancer Management | 15th Shanghai Urological Oncology Conference

Posted by By Mourabit Halima 2025.12.25
Editor’s Note: The 15th Shanghai Urological Oncology Academic Conference, hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urological Oncology Committee of the Shanghai Anti-Cancer Association and Fudan…
Read More
Professor Yao Zhu: The Clinical Transformation Already Underway—and Yet to Come—with Radioligand Therapy in Prostate Cancer

Professor Yao Zhu: The Clinical Transformation Already Underway—and Yet to Come—with Radioligand Therapy in Prostate Cancer

Posted by By Peter W. PENG 2025.12.25
15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…
Read More
Professor Yiping Zhu: Female Radical Cystectomy with Pelvic Organ Preservation

Professor Yiping Zhu: Female Radical Cystectomy with Pelvic Organ Preservation

Posted by By Mourabit Halima 2025.12.25
15th Shanghai Urologic Oncology Academic Conference Editor’s Note: Hosted by the Shanghai Anti-Cancer Association and jointly organized by the Urologic Oncology Committee of the Shanghai Anti-Cancer Association and Fudan University…
Read More
On-site from ESMO Asia | Dr. Yongbing Cheng (Team of Professor Guo Hongqian):

On-site from ESMO Asia | Dr. Yongbing Cheng (Team of Professor Guo Hongqian):

Posted by By Peng Longmei 2025.12.18
“Fewer Cores Without Losing Accuracy” — A New Strategy of MRI-Targeted Biopsy Plus Ipsilateral Systematic Biopsy of the Index Lesion in Prostate Cancer Editor’s Note: Prostate cancer is one of…
Read More
Professor Wasilijiang·Wahafu: Targeted Therapy Plus Immunotherapy Redefines Advanced Urothelial Carcinoma Care with Multidisciplinary Support

Professor Wasilijiang·Wahafu: Targeted Therapy Plus Immunotherapy Redefines Advanced Urothelial Carcinoma Care with Multidisciplinary Support

Posted by By Mourabit Halima 2025.12.18
Editor’s Note: Advanced urothelial carcinoma is a highly aggressive malignancy associated with poor prognosis, posing a serious threat to patient survival and quality of life. In recent years, continuous breakthroughs…
Read More
On-site from ESMO Asia | Professor Liangyou Gu: Disitamab Vedotin Plus Immunotherapy Brings New Hope for Adjuvant Treatment of UTUC

On-site from ESMO Asia | Professor Liangyou Gu: Disitamab Vedotin Plus Immunotherapy Brings New Hope for Adjuvant Treatment of UTUC

Posted by By Mourabit Halima 2025.12.18
Editor’s Note The incidence of upper tract urothelial carcinoma (UTUC) in China is significantly higher than in Western countries. Although radical nephroureterectomy remains the gold standard for treatment, a substantial…
Read More

Posts pagination

Previous page 1 2 3 4 5 6 … 20 Next page
Recent Posts
  • CASH 2026 Professor Wenbin Qian: Advancing Fourth-Generation CAR-T Therapy—Decoding Long-Term Efficacy, Resistance Mechanisms, and Future Directions
  • Annual Review Professor Bing Xu: Interpreting New Paradigms and Future Pathways in the Diagnosis and Treatment of Follicular Lymphoma
  • CASH 2026 Professor Jun Shi: New Insights into the Immune Mechanisms of Aplastic Anemia — Targeting CD38 and the JAK Pathway Shows Promising Therapeutic Potential
  • CASH 2026 Professor Erlie Jiang: Four Decades of Continuity and Innovation — The “Tianjin Model” Pioneering a New Era in Hematopoietic Stem Cell Transplantation
  • Lymphoma Roundtable · ASH Special Professor Qingqing Cai: New Advances in Bispecific Antibody Therapy for Relapsed/Refractory Lymphoma
Recent Comments
    Archives
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top